CVS Health Corporation Company Profile (NYSE:CVS)

About CVS Health Corporation

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Health Care Plans
  • Sub-Industry: Drug Retail
  • Exchange: NYSE
  • Symbol: CVS
  • CUSIP: 12665010
Key Metrics:
  • Previous Close: $87.57
  • 50 Day Moving Average: $89.01
  • 200 Day Moving Average: $95.55
  • 52-Week Range: $85.41 - $106.67
  • Trailing P/E Ratio: 20.14
  • Foreward P/E Ratio: 13.41
  • P/E Growth: 1.04
  • Market Cap: $93.37B
  • Outstanding Shares: 1,066,214,000
  • Beta: 0.83
  • Net Margins: 2.88%
  • Return on Equity: 15.86%
  • Return on Assets: 6.20%
  • Debt-to-Equity Ratio: 0.74%
  • Current Ratio: 1.11%
  • Quick Ratio: 0.57%
Additional Links:
Companies Related to CVS Health Corporation:

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (?)
Ratings Breakdown: 4 Hold Ratings, 17 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $112.77 (28.78% upside)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
DateFirmActionRatingPrice TargetDetails
10/18/2016Deutsche Bank AGReiterated RatingHold$108.00 -> $99.00View Rating Details
10/4/2016Credit Suisse Group AGReiterated RatingOutperform$115.00 -> $110.00View Rating Details
10/3/2016Robert W. BairdLower Price TargetOutperform$114.00 -> $104.00View Rating Details
10/2/2016Leerink SwannReiterated RatingOutperform$110.00 -> $105.00View Rating Details
9/30/2016MizuhoReiterated RatingBuy$111.00View Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00View Rating Details
8/8/2016Citigroup Inc.Lower Price TargetNeutral$115.00 -> $108.00View Rating Details
8/4/2016ArgusReiterated RatingBuy$120.00View Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00View Rating Details
7/4/2016Jefferies GroupReiterated RatingBuyView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00View Rating Details
5/4/2016Royal Bank Of CanadaReiterated RatingOutperform$110.00 -> $115.00View Rating Details
3/10/2016Barclays PLCBoost Price TargetOverweight$110.00 -> $115.00View Rating Details
2/10/2016GuggenheimLower Price TargetBuy$120.00 -> $115.00View Rating Details
2/10/2016Goldman Sachs Group Inc.Boost Price TargetNeutral$106.00 -> $110.00View Rating Details
2/3/2016Atlantic SecuritiesInitiated CoverageOverweight$114.00View Rating Details
12/18/2015Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00View Rating Details
11/2/2015Raymond James Financial Inc.Boost Price TargetOutperform$105.00 -> $110.00View Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00View Rating Details
11/2/2015JPMorgan Chase & Co.Lower Price TargetOverweight$128.00 -> $123.00View Rating Details
10/30/2015Evercore ISILower Price TargetBuy$111.00 -> $110.00View Rating Details
10/21/2015Cowen and CompanyLower Price Target$118.00 -> $113.00View Rating Details
2/11/2015Cantor FitzgeraldReiterated RatingHold$83.00View Rating Details
2/10/2015Noble FinancialReiterated RatingOutperformView Rating Details
1/21/2015StephensInitiated CoverageOverweightView Rating Details
1/2/2015Bank of America Corp.Set Price TargetBuy$94.00 -> $104.00View Rating Details
12/19/2014SunTrust Banks Inc.UpgradeNeutral -> Buy$92.00 -> $110.00View Rating Details
(Data available from 10/27/2014 forward)


Earnings History for CVS Health Corporation (NYSE:CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.20$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corporation (NYSE:CVS)
Current Year EPS Consensus Estimate: $5.85 EPS
Next Year EPS Consensus Estimate: $6.53 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$1.15$1.19$1.17
Q2 20166$1.30$1.36$1.31
Q3 20165$1.56$1.58$1.57
Q4 20165$1.77$1.79$1.78
Q1 20173$1.33$1.34$1.34
Q2 20173$1.48$1.59$1.52
Q3 20173$1.71$1.75$1.73
Q4 20173$1.91$2.00$1.97
Q1 20181$1.49$1.49$1.49
Q2 20181$1.62$1.62$1.62
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Annual Dividend:$1.70
Dividend Yield:1.94%
Dividend Growth:29.10% (3 Year Average)
Payout Ratio:39.08% (Based on Trailing 12 Months of Earnings)
29.06% (Based on Current Year Consensus EPS Estimate)
26.03% (Based on Next Year Consensus EPS Estimate)
Track Record:8 Years of Consecutive Dividend Growth

Dividend History for CVS Health Corporation (NYSE:CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for CVS Health Corporation (NYSE:CVS)
Insider Ownership Percentage: 0.58%
Institutional Ownership Percentage: 81.02%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CVS Health Corporation (NYSE:CVS)
DateHeadline logo2 Trending Stocks Reynolds American, Inc. (NYSE:RAI), CVS Health Corp (NYSE:CVS) - Wall Street 24 (NYSE:CVS) - October 26 at 4:35 PM logoCVS Health Corp. : CVS-US: Dividend Analysis : October 24th, 2016 (record date) : By the numbers : October 26, 2016 (NYSE:CVS) - October 26 at 4:35 PM logoHow To Significantly Increase Your CVS Income - Seeking Alpha (NYSE:CVS) - October 26 at 8:29 AM logoIs CVS a Better Buy than WBA? Here’s Wall Street’s View (NYSE:CVS) - October 26 at 8:29 AM
News IconNewsmaking Penny Stock: Investors Checking Out CVS Health Corporation (NYSE:CVS) - Duncan Research (NYSE:CVS) - October 25 at 4:32 PM logoCVS December 16th Options Begin Trading (NYSE:CVS) - October 25 at 9:23 AM
News IconKraus Co Lowers stake in CVS Health Corp (CVS) (NYSE:CVS) - October 25 at 9:23 AM
News IconLarge Cap Health Care Plans: CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - October 25 at 9:23 AM
News IconTrending Stocks in Review: Celgene Corporation (NASDAQ:CELG), CVS Health Corporation (NYSE:CVS) - The Newburgh Press (NYSE:CVS) - October 24 at 4:25 PM logoHow Walgreens Outdid Itself, Beat Its Own Guidance (NYSE:CVS) - October 24 at 4:25 PM
News IconStocks to Watch: CVS Health Corp (NYSE:CVS), Pandora Media Inc ... - NYSE Journal (press release) (NYSE:CVS) - October 24 at 9:44 AM
News IconHealth Care Plans: CVS Health Corporation (NYSE:CVS) Position of the day (NYSE:CVS) - October 23 at 9:07 AM logoCVS HEALTH CORP Financials (NYSE:CVS) - October 22 at 4:21 PM
News IconFirst Citizens Bank & Trust Co. Reduces Stake in CVS Health Corporation (CVS) (NYSE:CVS) - October 22 at 8:45 AM
News IconStreet Session Update on CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - October 22 at 8:45 AM
News IconCVS Health Corporation (CVS) Rating Reiterated by Deutsche Bank AG (NYSE:CVS) - October 22 at 8:45 AM
News IconCVS Health Corporation (NYSE:CVS) Assigned A Consensus Outperform Rating (NYSE:CVS) - October 22 at 8:45 AM
News IconCVS Health Corporation (NYSE:CVS) from Health Care Plans – Todays Top Gains (NYSE:CVS) - October 21 at 4:32 PM logo52-Week Company Lows (NYSE:CVS) - October 21 at 4:32 PM logoThe Attractiveness Of CVS At $86 Instead Of $106 - Seeking Alpha (NYSE:CVS) - October 21 at 8:38 AM logoCVS: Garage Sale Bargain - Seeking Alpha (NYSE:CVS) - October 21 at 8:38 AM logoCVS Health Corporation: Attractively Valued And Set Up For Double Digit Returns - Seeking Alpha (NYSE:CVS) - October 21 at 8:38 AM
News IconTop Gainers of the Day: CVS Health Corporation (NYSE:CVS) from Health Care Plans (NYSE:CVS) - October 19 at 4:55 PM logoCVS Health : Pharmacy to Help Patients Understand Health Insurance Options During Medicare Part D Open Enrollment for 2017 (NYSE:CVS) - October 19 at 9:27 AM logoCVS Health Corporation: Attractively Valued And Set Up For Double Digit Returns (NYSE:CVS) - October 19 at 9:27 AM logoEx-Dividend Reminder: CVS Health, Bard and AAR (NYSE:CVS) - October 18 at 4:26 PM logoHate Checking Your Portfolio? Try These 2 Stocks (NYSE:CVS) - October 18 at 4:26 PM logoBy the Numbers: How Health Consumers Weigh Cost and Quality (NYSE:CVS) - October 18 at 4:26 PM logoOpportunities Ahead: Merlo Discusses the Future of Health Care (NYSE:CVS) - October 18 at 4:26 PM logoDeferred Tax Assets Of CVS Health Corporation (NYSE:CVS) At $1220 (NYSE:CVS) - October 18 at 9:32 AM
News IconWebster Bank N. A. Lowers stake in CVS Health Corp (CVS) (NYSE:CVS) - October 18 at 9:32 AM logoJanuary 2019 Options Now Available For CVS Health (CVS) (NYSE:CVS) - October 18 at 9:32 AM
News IconUpdate on CVS Health Corporation (NYSE:CVS) for the day (NYSE:CVS) - October 18 at 9:32 AM logoWall Street Recommendations: WBA versus CVS and RAD (NYSE:CVS) - October 18 at 9:32 AM logoDeferred Tax Assets Of CVS Health Corporation (NYSE:CVS) At $1220 - (NYSE:CVS) - October 17 at 4:29 PM logoAnalyst Downgrades: CVS Health Corp, Dunkin Brands Group Inc, and Twitter Inc - Schaeffers Research (blog) (NYSE:CVS) - October 17 at 4:29 PM logoJanuary 2019 Options Now Available For CVS Health (CVS) - Forbes (NYSE:CVS) - October 17 at 4:29 PM logoOmnicare to shell out another $28M on kickback litigation (NYSE:CVS) - October 17 at 4:29 PM logoShopping CVS for More than a Flu Shot (NYSE:CVS) - October 17 at 9:29 AM logoJohnson & Johnson’s Medical Devices Segment: 3Q16 Estimates (NYSE:CVS) - October 17 at 9:29 AM
News IconLeading stocks in today’s market: CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - October 16 at 4:25 PM
News IconStock Tracker: Earnings & Estimates for CVS Health Corporation (NYSE:CVS) - CSZ News (NYSE:CVS) - October 16 at 9:11 AM logo3 Stocks to Watch For: MetLife, Inc. (MET), CVS Health Corporation (CVS), Baxter International Inc. (BAX) - iStreetWire (NYSE:CVS) - October 14 at 4:23 PM
News IconRetreated Mix Cap Active Movers- CVS Health Corporation (NYSE:CVS), Esperion Therapeutics, Inc. (NASDAQ:ESPR) - Seneca Globe (NYSE:CVS) - October 14 at 4:23 PM logoWhy I Am Now Interested In CVS Health Corp (CVS) (NYSE:CVS) - October 14 at 8:46 AM logoCVS Pharmacy to Help Patients Understand Health Insurance Options During Medicare Part D Open Enrollment for 2017 (NYSE:CVS) - October 14 at 8:46 AM logoSilverScript Insurance Company, a CVS Health Company, Introduces New Medicare Prescription Drug Plan Options for 2017 (NYSE:CVS) - October 14 at 8:46 AM logoUBS Makes Huge Q4 Addition to Popular Dividend Ruler Portfolio - 24/7 Wall St. (NYSE:CVS) - October 13 at 9:44 PM
News IconCVS Health Corporation's (CVS): Trader's Buzzer - Hot Stocks Point (NYSE:CVS) - October 13 at 9:44 PM
News IconInvestment Doubling Stocks on Cards: CVS Health Corporation (NYSE:CVS), GlaxoSmithKline plc (NYSE:GSK) - Street Wise Report (press release) (blog) (NYSE:CVS) - October 13 at 9:44 PM


CVS Health Corporation (NYSE:CVS) Chart for Thursday, October, 27, 2016

Last Updated on 10/27/2016 by Staff